BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Murphy MJ, Cohen JM, Vesely MD, Damsky W. Paradoxical eruptions to targeted therapies in dermatology: A systematic review and analysis. J Am Acad Dermatol 2020:S0190-9622(20)33154-6. [PMID: 33307146 DOI: 10.1016/j.jaad.2020.12.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Murphy MJ, Leasure AC, Damsky W, Cohen JM. Association of sarcoidosis with psoriasis: a cross-sectional study in the All of Us research program. Arch Dermatol Res 2022. [DOI: 10.1007/s00403-022-02488-z] [Reference Citation Analysis]
2 Reinhart JP, Aird JL, Stephens MC, Asch S, Orandi AB, Tollefson MM. Tumor necrosis factor‐α inhibitor‐induced morphea and psoriasiform dermatitis in a pediatric patient with Crohn's disease. Pediatric Dermatology 2022. [DOI: 10.1111/pde.15182] [Reference Citation Analysis]
3 Derbyshire M, Beatty C, Marks K, Kazlouskaya V. Lichenoid eruption during treatment of atopic dermatitis with dupilumab. Int J Dermatol 2022. [PMID: 36250258 DOI: 10.1111/ijd.16465] [Reference Citation Analysis]
4 Park A, Wong L, Lang A, Kraus C, Anderson N, Elsensohn A. Cutaneous T-cell lymphoma following dupilumab use: a systematic review. Int J Dermatol 2022. [PMID: 36073768 DOI: 10.1111/ijd.16388] [Reference Citation Analysis]
5 Miyagawa F. Pathogenesis of Paradoxical Reactions Associated with Targeted Biologic Agents for Inflammatory Skin Diseases. Biomedicines 2022;10:1485. [DOI: 10.3390/biomedicines10071485] [Reference Citation Analysis]
6 Tsai Y, Tsai T. Overlapping Features of Psoriasis and Atopic dermatitis: From Genetics to Immunopathogenesis to Phenotypes. IJMS 2022;23:5518. [DOI: 10.3390/ijms23105518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yamane S, Nakagawa Y, Inui S, Fujimoto M. Development of alopecia areata-like reactions in a patient treated with dupilumab. Allergol Int 2022:S1323-8930(22)00015-6. [PMID: 35346581 DOI: 10.1016/j.alit.2022.02.006] [Reference Citation Analysis]
8 Brown SJ. Atopic eczema: How genetic studies can contribute to understanding this complex trait. J Invest Dermatol 2022:S0022-202X(21)02638-5. [PMID: 35007558 DOI: 10.1016/j.jid.2021.12.020] [Reference Citation Analysis]
9 Choo KJL, Yeo YW. Cutaneous Adverse Reactions to Biologic Agents. Drug Eruptions 2022. [DOI: 10.1007/978-3-031-09388-3_24] [Reference Citation Analysis]
10 Sano H, Maeda T, Sato R, Shimizu F, Koga M, Kanda T. Acute sarcoid myopathy and neuropathy aggravated by ustekinumab administration in an elderly woman with psoriasis and systemic sarcoidosis. Rinsho Shinkeigaku. [DOI: 10.5692/clinicalneurol.cn-001714] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 McFeely O, Pender E, Victory L, Almutlaq H, Storan E. Risankizumab-induced paradoxical pustular psoriasis. Clin Exp Dermatol 2021. [PMID: 34748673 DOI: 10.1111/ced.15006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Damsky W, Wang A, Young BD, Ayasun R, Ryu C, Mcgeary MK, Fazzone-chettiar R, Pucar D, Gulati M, Miller EJ, Bosenberg M, Flavell RA, King B. Treatment of sarcoidosis with cutaneous involvement with tofacitinib.. [DOI: 10.1101/2021.07.01.21259700] [Reference Citation Analysis]
13 Narla S, Silverberg JI, Simpson EL. Management of inadequate response and adverse effects to dupilumab in atopic dermatitis. J Am Acad Dermatol 2021:S0190-9622(21)01119-1. [PMID: 34126094 DOI: 10.1016/j.jaad.2021.06.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 13.0] [Reference Citation Analysis]
14 Qi HJ, Li LF. New Biologics for the Treatment of Atopic Dermatitis: Analysis of Efficacy, Safety, and Paradoxical Atopic Dermatitis Acceleration. Biomed Res Int 2021;2021:5528372. [PMID: 34195265 DOI: 10.1155/2021/5528372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Sherman S, Tzur Bitan D, Leshem YA, Hodak E. Reply to: Comments on "Hidradenitis suppurativa and atopic dermatitis: A two-way association". J Am Acad Dermatol 2021:S0190-9622(21)01004-5. [PMID: 34044104 DOI: 10.1016/j.jaad.2021.05.019] [Reference Citation Analysis]